These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
752 related items for PubMed ID: 9645762
21. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Niedobitek G, Agathanggelou A, Nicholls JM. Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600 [Abstract] [Full Text] [Related]
22. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma. Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M. Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696 [Abstract] [Full Text] [Related]
23. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. Cabras G, Decaussin G, Zeng Y, Djennaoui D, Melouli H, Broully P, Bouguermouh AM, Ooka T. J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121 [Abstract] [Full Text] [Related]
24. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. Schlager S, Speck SH, Woisetschläger M. J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690 [Abstract] [Full Text] [Related]
25. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Lu J, Chua HH, Chen SY, Chen JY, Tsai CH. Cancer Res; 2003 Jan 01; 63(1):256-62. PubMed ID: 12517806 [Abstract] [Full Text] [Related]
26. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF. Clin Cancer Res; 2002 Aug 01; 8(8):2612-9. PubMed ID: 12171892 [Abstract] [Full Text] [Related]
27. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. Heussinger N, Büttner M, Ott G, Brachtel E, Pilch BZ, Kremmer E, Niedobitek G. J Pathol; 2004 Jun 01; 203(2):696-9. PubMed ID: 15141385 [Abstract] [Full Text] [Related]
28. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Tsai ST, Jin YT, Mann RB, Ambinder RF. Cancer; 1998 Apr 15; 82(8):1449-53. PubMed ID: 9554519 [Abstract] [Full Text] [Related]
29. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Snudden DK, Smith PR, Lai D, Ng MH, Griffin BE. Oncogene; 1995 Apr 20; 10(8):1545-52. PubMed ID: 7731709 [Abstract] [Full Text] [Related]
30. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines. Lin CT, Chen W, Hsu MM, Dee AN. Lab Invest; 1997 Jun 20; 76(6):793-8. PubMed ID: 9194855 [Abstract] [Full Text] [Related]
31. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W, Sun X. Biomed Pharmacother; 2018 Jun 20; 102():1003-1014. PubMed ID: 29710517 [Abstract] [Full Text] [Related]
32. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ. J Med Virol; 1996 Dec 20; 50(4):314-21. PubMed ID: 8950688 [Abstract] [Full Text] [Related]
33. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D. Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY. Cancer Epidemiol Biomarkers Prev; 1997 May 20; 6(5):363-8. PubMed ID: 9149897 [Abstract] [Full Text] [Related]
34. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Seto E, Ooka T, Middeldorp J, Takada K. Cancer Res; 2008 Feb 15; 68(4):1030-6. PubMed ID: 18281477 [Abstract] [Full Text] [Related]
35. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. Tiwawech D, Srivatanakul P, Karalak A, Ishida T. J Clin Virol; 2008 May 15; 42(1):1-6. PubMed ID: 18180201 [Abstract] [Full Text] [Related]
36. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells. Chang MH, Ng CK, Lin YJ, Liang CL, Chung PJ, ChenML, Tyan YS, Hsu CY, Shu CH, Chang YS. DNA Cell Biol; 1997 Jul 15; 16(7):829-37. PubMed ID: 9260926 [Abstract] [Full Text] [Related]
37. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH, Chen CL, Li WY, Chen CJ. Carcinogenesis; 2009 Aug 15; 30(8):1443-51. PubMed ID: 19483191 [Abstract] [Full Text] [Related]
38. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M, Eizuru Y, Ooka T, Takada K. J Med Virol; 2005 May 15; 76(1):82-8. PubMed ID: 15778977 [Abstract] [Full Text] [Related]
39. [Expression of Epstein-Barr virus A73 gene in nasopharyngeal carcinoma tissues and its subcellular location]. Li A, Zhang XS, Wang HH, Jiang JH, Liu XQ, Liu QC, Zeng YX. Ai Zheng; 2003 Jun 15; 22(6):597-601. PubMed ID: 12948408 [Abstract] [Full Text] [Related]
40. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients. Burgos JS, Vera-Sempere FJ. Anticancer Res; 2001 Jun 15; 21(6A):3921-4. PubMed ID: 11911270 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]